96725 ⎘
Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof containing only normal peptide links; Tetrapeptides with the first amino acid being neutral and aromatic or cycloaliphatic
PEPTIDES FOR INCRETIN SYNTHESIS
#2BETA-PEPTIDES AND BETA-PEPTIDE HYDROGELS
#3MITOCHONDRIA-TARGETING PEPTIDES
#4CYCLIC PEPTIDE DERIVATIVE, METHOD FOR PRODUCING SAME, AND COMPOSITION
#5Method for Synthesizing Amide and/or Polypeptide Using Temporary Protected Amino Acid as Ammonia Component
#6FAP-ACTIVATED PROTEASOME INHIBITORS FOR TREATING SOLID TUMORS
#7PROBIOTIC MOLECULES FOR REDUCING PATHOGEN VIRULENCE
#8CANCER-TARGETING PEPTIDE, PRODRUG NANOPARTICLES COMPRISING SAME, AND PHARMACEUTICAL COMPOSITION COMPRISING SAME FOR CANCER PREVENTION OR TREATMENT
#9PROBIOTIC BACTERIAL MOLECULES AND THEIR USE IN METHODS TO TREAT/PREVENT INFECTION BY HARMFUL BACTERIA AND TO PROVIDE NUTRITIONAL HEALTH
#10METHODS FOR REDUCING CD36 EXPRESSION
#11COMPOSITIONS AND METHODS FOR PURIFYING BIOLOGICAL FLUIDS
#12METHODS AND COMPOSITIONS FOR THE PREVENTION AND TREATMENT OF DUCHENNE MUSCULAR DYSTROPHY
#13DRUG CONJUGATES FOR BONE MARROW PROTECTION
#14METHODS FOR THE TREATMENT OF MITOCHONDRIAL DISEASE
#15KAPPA OPIOID RECEPTOR PEPTIDE AMIDE LIGANDS
#16Polymer Agonists of Mu Opioid Receptors
#17Protease inhibitors
#18AROMATIC-CATIONIC PEPTIDES AND USES OF SAME
#19Biological Production of Histidine-Rich Peptides
#20COMPOUNDS AND COMPOSITIONS THEREOF FOR THE TREATMENT OF CANCER
#21FRET ENZYMATIC SUBSTRATE AND USES THEREOF IN LUNG CANCER
#22AROMATIC-CATIONIC PEPTIDES AND USES OF SAME
#23PYRROLIDINE CARBOXAMIDO DERIVATIVES AND METHODS FOR PREPARING AND USING THE SAME
#24FLEXIBLE DRY SPRINKLER HAVING A DIFFERENTIAL PRESSURE CONTROLLER
#25method for the treatment of pain and a medicinal product for administration during pain
#26PROBIOTIC MOLECULES FOR REDUCING PATHOGEN VIRULENCE
#27DEUTERATED TETRAPEPTIDES THAT TARGET MITOCHONDRIA
#28Proteasome Inhibitors
#29THIOPHOSPHOPEPTIDES FOR ULTRAFAST TARGETING OF THE GOLGI APPARATUS
#30MELANOCORTIN LIGANDS AND METHODS OF USE THEREOF
#31RESPIRATORY TREATMENTS
#32METHODS FOR PREVENTION AND TREATMENT OF ACUTE RENAL INJURY
#33Methods and compositions for preventing or treating ophthalmic conditions
#34TREATMENT OF HMGB1-MEDIATED INFLAMMATION
#35METHODS AND COMPOSITIONS FOR PREVENTING OR TREATING OPHTHALMIC CONDITIONS
#36Flexible dry sprinkler having a differential pressure controller
#37METHODS FOR PREVENTING OR TREATING MITOCHONDRIAL PERMEABILITY TRANSITION
#38Methods for the prevention or treatment of heart failure
#39PRODRUGS OF MITOCHONDRIA-TARGETING OLIGOPEPTIDES
#40METHODS FOR THE TREATMENT OF MITOCHONDRIAL DISEASE
#41CBX8 chromdomain inhibitors and the uses thereof
#42PRODRUGS OF MITOCHONDRIA-TARGETING OLIGOPEPTIDES
#43PROBIOTIC BACTERIAL MOLECULES AND THEIR USE IN METHODS TO TREAT/PREVENT INFECTION BY HARMFUL BACTERIA AND TO PROVIDE NUTRITIONAL HEALTH
#44METHODS FOR REDUCING CD36 EXPRESSION
#45HMGB1 antagonist treatment of severe sepsis
#46MACROCYCLIC BROAD SPECTRUM ANTIBIOTICS
#47PEPTIDES AND PHARMACEUTICAL, NUTRACEUTICAL OR VETERINARY COMPOSITIONS FOR HAIR LOSS PREVENTION AND/OR TREATMENT
#48METHODS AND COMPOSITIONS FOR THE PREVENTION AND TREATMENT OF DUCHENNE MUSCULAR DYSTROPHY
#49HEPATITIS C VIRUS NS3/4A PROTEASE INHIBITORS
#50COMPOSITIONS AND METHODS FOR IN SITU-FORMING GELS FOR WOUND HEALING AND TISSUE REGENERATION
#51PYRROLIDINE CARBOXAMIDO DERIVATIVES AND METHODS FOR PREPARING AND USING THE SAME
#52Method and carrier complexes for delivering molecules to cells
#53ADVANTAGEOUS SALTS OF MU-OPIATE RECEPTOR PEPTIDES
#54COMPOUNDS FOR PROTEASOME ENZYME INHIBITION
#55Peptide epoxyketone proteasome inhibitors in combination with PIM kinase inhibitors for treatment of cancers
#56Polymer agonists of mu opioid receptors
#57HEPATITIS C VIRUS NS3/4A PROTEASE INHIBITORS
#58MEMBRANE PROTEASE-BASED METHODS FOR DETECTION OF BACTERIA
#59INHIBITORS OF GROWTH FACTOR ACTIVATION ENZYMES
#60MITOCHONDRIA-TARGETING PEPTIDES
#61METHOD FOR PRODUCING PEPTIDE COMPOUND, PROTECTIVE GROUP-FORMING REAGENT, AND CONDENSED POLYCYCLIC AROMATIC HYDROCARBON COMPOUND
#62FAP-activated proteasome inhibitors for treating solid tumors
#63Crystalline salt forms of SBT-20
#64ADVANTAGEOUS MU-OPIATE RECEPTOR PEPTIDE COMPOUNDS
#65LLP2A-BISPHOSPHONATE CONJUGATES FOR OSTEOPOROSIS TREATMENT
#66PROCESS FOR THE LIQUID PHASE SYNTHESIS OF H-INP-(D)BAL-(D)TRP-PHE-APC-NH2, AND PHARMACEUTICALLY ACCEPTABLE SALTS THEREOF
#67PEPTIDOMIMETIC INHIBITORS OF THE PEPTIDYL-PROLYL CIS/TRANS ISOMERASE (PIN1)
#68Methods for the synthesis of arginine-containing peptides
#69MACROCYCLIC BROAD SPECTRUM ANTIBIOTICS
#70PROCESS FOR SYNTHESIS OF PEPTIDE COMPOUNDS
#71Toll-like receptor 4 (TLR4) inhibitors and use thereof
#72METHODS FOR THE PREVENTION OR TREATMENT OF HEART FAILURE
#73COMPOUNDS FOR PROTEASOME ENZYME INHIBITION
#74Methods and compositions for preventing or treating ophthalmic conditions
#75Polypeptide compound, pharmaceutical composition, preparation method and application thereof
#76AROMATIC-CATIONIC PEPTIDES AND USES OF SAME
#77Treatment of HMGB1-mediated inflammation
#78Methods for reducing CD36 expression
#79Kappa opioid receptor peptide amide ligands
#80Aromatic-cationic peptides and uses of same
#81Methods for prevention and treatment of acute renal injury
#82Sunflower seed protein-derived peptides
#83Analgesic mu-opioid receptor binding peptide pharmaceutical formulations and uses thereof
#84HMGB1 antagonist treatment of severe sepsis
#85METHODS FOR THE TREATMENT OF MITOCHONDRIAL DISEASE
#86CHIRAL PEPTIDES
#87CBX8 chromdomain inhibitors and the uses thereof
#88LLP2A-BISPHOSPHONATE CONJUGATES FOR OSTEOPOROSIS TREATMENT
#89DEUTERATED TETRAPEPTIDES THAT TARGET MITOCHONDRIA
#90HMGB1 antagonist treatment of acute lung injury
#91HMGB1 antagonist treatment of diabetic peripheral neuropathy
#92HMGB1 antagonist
#93ADVANTAGEOUS SALTS OF MU-OPIATE RECEPTOR PEPTIDES
#94ENDOMORPHIN-2, TETRAPEPTIDE DERIVATIVES THEREOF, AND USES THEREOF
#95NOVEL THERAPEUTIC USES OF MU-OPIATE RECEPTOR PEPTIDES
#96Compounds for proteasome enzyme inhibition
#97FAP-activated proteasome inhibitors for treating solid tumors
#98Therapeutic compositions including frataxin, lactoferrin, and mitochondrial energy generating enzymes, and uses thereof
#99Macrocyclic therapeutic agents, methods of manufacture, and methods of treatment
#100Method and carrier complexes for delivering molecules to cells
#101METHOD FOR PRODUCING PEPTIDE COMPOUND
#102PEPTIDE EPOXYKETONE PROTEASOME INHIBITORS IN COMBINATION WITH PIM KINASE INHIBITORS FOR TREATMENT OF CANCERS
#103Polymer agonists of mu opioid receptors
#104Methods for the prevention or treatment of heart failure
#105PROBIOTIC BACTERIAL MOLECULES AND THEIR USE IN METHODS TO TREAT/PREVENT INFECTION BY HARMFUL BACTERIA AND TO PROVIDE NUTRITIONAL HEALTH
#106PROCESS FOR THE LIQUID PHASE SYNTHESIS OF H-INP-(D)BAL-(D)TRP-PHE-APC-NH2, AND PHARMACEUTICALLY ACCEPTABLE SALTS THEREOF
#107Detergent Composition
#108NEUTRAL-CATIONIC PEPTOIDS AND USES THEREOF
#109Peptide capable of forming a gel for use in tissue engineering and bioprinting
#110Polyamide compound and use thereof
#111Hepatitis C virus NS3/4A protease inhibitors
#112COMPOUNDS FOR PROTEASOME
#113METHODS AND COMPOSITIONS FOR PREVENTING OR TREATING OPHTHALMIC CONDITIONS
#114METHODS FOR PREVENTING OR TREATING MITOCHONDRIAL PERMEABILITY TRANSITION
#115MACROCYCLIC BROAD SPECTRUM ANTIBIOTICS
#116Enzymatically activatable peptide-redox modulator conjugates and use thereof
#117Growth Hormone Releasing Peptides
#118Probiotic molecules for reducing pathogen virulence
#119INSULIN A-CHAIN DERIVED PEPTIDE FRAGMENT AND PHARMACEUTICAL COMPOSITION FOR PREVENTING OR TREATING DIABETES OR DIABETIC WOUNDS, CONTAINING THE SAME
#120METHODS FOR PREVENTION AND TREATMENT OF ACUTE RENAL INJURY
#121PEPTIDOMIMETICS AND THEIR USE IN THERAPY
#122METHOD FOR ENHANCING EXTRACELLULAR VESICLE PRODUCTION
#123Fine-tune modulators of neuronal excitability for neuropsychiatric disorders
#124Peptide-based proteasome inhibitors for treating conditions mediated by senescent cells and for treating cancer
#125ENDOMORPHIN-2, TETRAPEPTIDE DERIVATIVES THEREOF, AND USES THEREOF
#126METHODS FOR REDUCING CD36 EXPRESSION
#127MACROCYCLIC THERAPEUTIC AGENTS, METHODS OF MANUFACTURE, AND METHODS OF TREATMENT
#128Synthetic peptide amides
#129PEPTIDE EPOXYKETONE PROTEASOME INHIBITORS IN COMBINATION WITH PIM KINASE INHIBITORS FOR TREATMENT OF CANCERS
#130Process for purification of carfilzomib intermediate
#131COMPOUNDS FOR PROTEASOME ENZYME INHIBITION
#132Synthetic peptide amides and dimers thereof
#133Chiral peptides
#134Peptides and pharmaceutical, nutraceutical or veterinary compositions for hair loss prevention and/or treatment
#135PHENYL PROPANAMIDE DERIVATIVE, AND MANUFACTURING METHOD AND PHARMACEUTICAL APPLICATION THEREOF
#136Retro-inverso peptide inhibitors of cell migration, extracellular matrix and endothelial invasion by tumor cells
#137Neuropeptide S receptor (NPSR) agonists
#138Water-soluble peptide fluorescence material
#139AROMATIC-CATIONIC PEPTIDES AND USES OF SAME
#140Cyclic peptide derivative, method for preparing same and composition thereof
#141FAP-activated proteasome inhibitors for treating solid tumors
#142THERAPEUTIC COMPOSITIONS INCLUDING PHENAZINE-3-ONE AND PHENOTHIAZINE-3-ONE DERIVATIVES AND USES THEREOF
#143Analgesic mu-opioid receptor binding peptide pharmaceutical formulations and uses thereof
#144AROMATIC-CATIONIC PEPTIDES AND USES OF SAME
#145Treatment of HMGB1-mediated inflammation
#146EPITOPES IN AMYLOID BETA AND CONFORMATIONALLY-SELECTIVE ANTIBODIES THERETO
#147Gelatinase inhibitors and use thereof
#148Process for the preparation of (2S)-N-((S)-1-((S)-4-methyl-1-((R)-2-methyl oxiran-2-yl)-1-oxopentan-2-ylcarbamoyl)-2-phenylethyl)-2-((S)-2-(2-morpholinoacetamido)-4-phenylbutanamido)-4-methylpentanamide
#149ANTIBIOTIC OLIGOPEPTIDES
#150ADVANTAGEOUS SALTS OF MU-OPIATE RECEPTOR PEPTIDES
#151NOVEL THERAPEUTIC USES OF MU-OPIATE RECEPTOR PEPTIDES
#152Short-chain peptides as Kappa (κ) opioid receptors (KOR) agonist
#153Biologically Cleavable Tetrapeptide Linking Agents
#154ADVANTAGEOUS MU-OPIATE RECEPTOR PEPTIDE COMPOUNDS
#155METHODS FOR THE PREVENTION OR TREATMENT OF HEART FAILURE
#156Drug for the effective control of acute and or chronic pain and a method for its administration
#157Method for preventing, improving, or treating inflammatory bowel disease
#158COMPOUNDS FOR PROTEASOME ENZYME INHIBITION
#159Peptidomimetics for imaging the ghrelin receptor
#160Prodrugs of peptide epoxy ketone protease inhibitors
#161Dipeptidyl peptidase-IV (DPPIV), inhibitory peptide compound, composition containing the same, and production method for the same
#162PERIPHERAL KAPPA OPIOID RECEPTOR AGONISTS FOR UREMIC PRURITUS IN DIALYSIS PATIENTS
#163Inhibitors of growth factor activation enzymes
#164Water-soluble peptide fluorescence material
#165METHODS OF MAKING CARFILZOMIB AND INTERMEDIATES THEREOF
#166Probiotic bacterial molecules and their use in methods to treat/prevent infection by harmful bacteria and to provide nutritional health
#167MU OPIOID RECEPTOR AGONIST ANALOGS OF THE ENDOMORPHINS
#168Growth Hormone Releasing Peptides
#169P21-ACTIVATED KINASE INHIBITOR
#170NEUROTOXIC TARGET FOR AMYLOSPHEROID, METHOD AND MATERIAL FOR REDUCING THE NEUROTOXICITY OF AMYLOSPHEROID, AND USE THEREOF
#171Methods and compositions for preventing or treating ophthalmic conditions
#172METHODS FOR REDUCING CD36 EXPRESSION
#173NUCLEIC ACIDS FOR TREATMENT OF PEANUT ALLERGIES
#174Process for the preparation of (S)-4-methyl-N-((S)-1-(((S)-4-methyl-1-((R)-2-methyloxiran-2-yl)-1-oxo-pentan-2-yl) amino)-1-oxo-3-phenylpropan-2-yl)-2-((S)-2-(2-morpholinoacetamido)-4-phenylbutanamido) pentanamide
#175Rho associated kinase (ROCK) inhibitors and their use in treating disease
#176TUBULYSIN COMPOUNDS, METHODS OF MAKING AND USE
#177GADD45BETA/MKK7 INHIBITOR FOR THE TREATMENT OF A RESISTANT HAEMATOLOGICAL MALIGNANCY
#178Smart Pro-Drugs of Serine Protease Inhibitors
#179PROCESS FOR THE LIQUID PHASE SYNTHESIS OF H-INP-(D)BAL-(D)TRP-PHE-APC-NH2, AND PHARMACEUTICALLY ACCEPTABLE SALTS THEREOF
#180Glycopeptide for contrast agent targeting cancer cells and contrast agent kit containing the same
#181Methods and compositions for treating pain
#182Therapeutic compositions including frataxin, lactoferrin, and mitochondrial energy generating enzymes, and uses thereof
#183LLP2A-bisphosphonate conjugates for osteoporosis treatment
#184PHARMACEUTICALLY RELEVANT AROMATIC-CATIONIC PEPTIDES
#185USE OF AROMATIC-CATIONIC PEPTIDES TO TREAT CHOLESTEROL-INDUCED MITOCHONDRIAL DYSFUNCTION
#186Synthetic peptides, enzymatic formation of pericellular hydrogels/nanofibrils, and methods of use
#187Method and carrier complexes for delivering molecules to cells
#188AROMATIC-CATIONIC PEPTIDES AND USES OF SAME
#189Synthetic peptide amides and dimers thereof
#190Synthetic peptide amides
#191Biologically cleavable tetrapeptide linking agents
#192Antibody drug conjugates (ADCs) with kinesin spindel protein (KSP)
#193FAP-activated proteasome inhibitors for treating solid tumors
#194Methods of making carfilzomib and intermediates thereof
#195Gamma amino acid building blocks
#196Tubulysin compounds, methods of making and use
#197Prodrugs of peptide epoxy ketone protease inhibitors
#198Cell-free protein synthesis method and device using a eukaryotic cell lysate in the presence of a caspase inhibitor and the use of a caspase inhibitor for increasing the yield and/or the stability of the synthesized proteins in such a method
#199THERAPEUTIC COMPOSITIONS INCLUDING PHENAZINE-3-ONE AND PHENOTHIAZINE-3-ONE DERIVATIVES AND USES THEREOF
#200Composition comprising peptide derived from adiponectin
#201COMPOUNDS FOR PROTEASOME ENZYME INHIBITION
#202SYNTHESIS OF PEPTIDE EPOXY KETONES
#203Dipeptidyl peptidase-IV (DPPIV), inhibitory peptide compound, composition containing the same, and production method for the same
#204Short peptides and a method of use as an antioxidant
#205PEPTIDE EPOXYKETONE PROTEASOME INHIBITORS IN COMBINATION WITH PIM KINASE INHIBITORS FOR TREATMENT OF CANCERS
#206Compositions and methods of treatment of cancers
#207Proprotein convertase subtilisin kexin type 9 (PCSK9) allosteric binding ligands to modulate serum low density lipoprotein (LDL) levels
#208LLP2A-bisphosphonate conjugates for osteoporosis treatment
#209Methods and compositions for preventing or treating ophthalmic conditions
#210Agent derived from tortoise spleen stimulating mammalian hemopoiesis
#211Tunable control of protein degradation in synthetic and endogenous bacterial systems
#212Methods for the treatment of mitochondrial diseases associated with a mutation in or gene resulting in a disruption of mitochondrial oxidative phosphorylation
#213Short peptides and a method of use as an antioxidant
#214Gadd45beta targeting agents
#215COMPOUNDS FOR PROTEASOME ENZYME INHIBITION
#216METHODS FOR PREVENTION AND TREATMENT OF ACUTE RENAL INJURY
#217Compounds for enzyme inhibition
#218HYDROGELATORS COMPRISING D-AMINO ACIDS
#219Mucin hypersecretion inhibitors and methods of use
#220Synthetic peptide amides
#221RFamide-related peptides and methods thereof
#222Synthesis of telaprevir and boceprevir, or pharmaceutically acceptable salts or solvates as well as intermediate products thereof including β-amino acids prepared via Mukaiyama aldol addition
#223HCV protease inhibitors and uses thereof
#224Uses of kappa opioid synthetic peptide amides
#225ADVANTAGEOUS SALTS OF MU-OPIATE RECEPTOR PEPTIDES
#226Methods and compositions for treating pain
#227Gamma amino acid building blocks
#228Tubulysin compounds, methods of making and use
#229Novel Therapeutic Uses of Mu-Opiate Receptor Peptides
#230Process for the Production of Bivalirudin
#231AROMATIC-CATIONIC PEPTIDES AND USES OF SAME
#232Growth hormone releasing peptides
#233Eye drops
#234Cyclin based inhibitors of CDK2 and CDK4
#235Synthetic peptide amides and dimers thereof
#236Organic compounds and their uses
#237Agent derived from tortoise spleen stimulating mammalian hemopoiesis
#238COMPOSITION FOR IMPROVING BRAIN FUNCTION AND METHOD FOR IMPROVING BRAIN FUNCTION
#239HEMIASTERLIN DERIVATIVES AND USES THEREOF IN THE TREATMENT OF CANCER
#240Peptidomimetics and their application
#241Methods and compositions for treating pain
#242METHODS FOR REDUCING CD36 EXPRESSION
#243FAP-activated proteasome inhibitors for treating solid tumors
#244Methods for reducing CD36 expression
#245Peptide derivatives for treatment, prevention or alleviation of a condition associated with bone loss or low bone density or to inhibit osteoclast differentiation and stimulation
#246Antineoplastic hydrogels, and enzyme-instructed preparations thereof
#247Tubulysin compounds, methods of making and use
#248Methods of facilitating neural cell survival using non-peptide and peptide BDNF neurotrophin mimetics
#249Substituted piperazin-2,5-diones as multifunctional bioactive compounds
#250Compound and method for modulating opioid receptor activity
#251Advantageous salts of μ-opiate receptor peptides
#252Locally-active anticoagulants and anti-inflammatory agents
#253Template-fixed peptidomimetics
#254Prodrugs of peptide epoxy ketone protease inhibitors
#255METHODS FOR THE PREVENTION OR TREATMENT OF HEART FAILURE
#256Prodrugs of peptide epoxy ketone protease inhibitors
#257sGCalphal inhibiting compositions
#258LLP2A-bisphosphonate conjugates for osteoporosis treatment
#259Methods and compositions for preventing or treating ophthalmic conditions
#260Neuroprotective and neurorestorative methods and compositions
#261Mucin hypersecretion inhibitors and methods of use
#262Peptides and methods using same for diagnosis and treatment of amyloid-associated disease
#263HCV protease inhibitors and uses thereof
#264Compounds For Enzyme Inhibition
#265Smart pro-drugs of serine protease inhibitors
#266Methods for preventing or treating mitochondrial permeability transition
#267Bioactive peptide
#268Methods of using halogenated peptides as internal standards for liquid chromatography-mass spectrometry
#269Macrocyclic kinase inhibitors and uses thereof
#270HCV NS3 PROTEASE INHIBITORS
#271Neurotoxic target for amylospheroid, method and material for reducing the neurotoxicity of amylospheroid, and use thereof
#272ISOLATION OF MESENCHYMAL STEM CELLS
#273Crystalline peptide epoxy ketone protease inhibitors and the synthesis of amino acid keto-epoxides
#274Crystalline peptide epoxy ketone protease inhibitors and the synthesis of amino acid keto-epoxides
#275Lipid peptide and hydrogel
#276Agent derived from tortoise spleen stimulating mammalian hemopoiesis
#277Growth hormone releasing peptides
#278INHIBITORS OF SERINE PROTEASES, PARTICULARLY HCV NS3-NS4A PROTEASE
#279Inhibitors of the trypsin-like site of the proteasome and methods of use thereof
#280PROCESSES AND INTERMEDIATES
#281Peptides or Antibodies Which Bind to Melanoma Inhibitory Activity (MIA) Protein
#282Method and carrier complexes for delivering molecules to cells
#283AROMATIC-CATIONIC PEPTIDES AND USES OF SAME
#284Compounds for enzyme inhibition
#285Compounds for enzyme inhibition
#286Compounds for enzyme inhibition
#287Peptidomimetic sulfamide compounds and antiviral uses thereof
#288C-Met receptor regulation by angiotensin IV (AT4) receptor ligands
#289Peptidomimetic sulfamide compounds and antiviral uses thereof
#290Methods for prevention and treatment of acute renal injury
#291Synthetic peptide amides for pain
#292OPTIMIZED METHOD FOR OBTAINING ACE ACTIVITY INHIBITORY PEPTIDES FROM WHEY, ACE INHIBITORY PEPTIDES AND FOOD COMPRISING THEM
#293SERINE HYDROLASE FORMULATION
#294Hemiasterlin derivatives and uses thereof in the treatment of cancer
#295Peptidomimetic protease inhibitors
#296Gadd45beta targeting agents
#297Compounds For Enzyme Inhibition
#298REGULATION OF AUTOPHAGY PATHWAY PHOSPHORYLATION AND USES THEREOF
#299Organic compounds and their uses
#300THERAPEUTIC AGENT FOR GASTROINTESTINAL DISEASE